These two posts address the same critical issue - those with dubious agendas whose modus operandi of complete self interest damages this medical development Australian Company and its committed shareholders and staff.
dingle:
"The really sad thing is that so many stem cell scientists devote their professional lives to discovering and adding value to this science with the objective of improving the health of so many people and yet there exists this army of amoral greedy destructive bottom feeders who work to bring all their good work undone.
Beneath contempt."
dolcevita: (referencing madamanswer)
"indeed. Why sit here day after day, year after year telling us what is immediately obvious but ignoring the elephant in the room?
Why? Because the monster will begin to move and when it does it will be very very difficult to get on board cheaply. So best to ignore the elephant and bang away at the blindingly obvious. Ad nauseum. Mum & dad investors who got shaken out will not thank the person who encouraged them to sell out cheap. No. They will not."
- Forums
- ASX - By Stock
- Playing a dangerous game
These two posts address the same critical issue - those with...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 71720 | 94.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 10463 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65720 | 0.940 |
3 | 31070 | 0.935 |
4 | 85753 | 0.930 |
2 | 9000 | 0.925 |
5 | 75776 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 10463 | 1 |
0.950 | 50000 | 2 |
0.955 | 64000 | 1 |
0.960 | 30220 | 3 |
0.965 | 44050 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |